Blossom® Smart Expander Device for Tissue Expander/Implant-Based Breast Reconstruction
NCT: NCT05975372 · RECRUITING
Brief Summary
The conventional breast tissue expander used for breast reconstruction/ augmentation requires weekly or biweekly injections of saline through the skin and into an integrated port in the implant using a needle and syringe in order to expand breast skin, which is an in-office procedure and can be uncomfortable for patients. Blossom Smart Expander Technology, currently available on the market, aims to achieve the same tissue expansion while avoiding frequent injections through the skin by means of an expansion device that slowly and continuously injects a very small amount of saline. Expansion of the device is based on pressure and volume in the expander, allowing for a tailored expansion process for individual patients' physiology. The purpose of this study is to assess the clinical effectiveness of Blossom Smart Expander Technology in 2-staged tissue expander/implant-based breast reconstruction/ augmentation compared to standard tissue expansion methods.
Frequently Asked Questions
What is Blossom® Smart Expander Device for Tissue Expander/Implant-Based Breast Reconstruction?
Blossom® Smart Expander Device for Tissue Expander/Implant-Based Breast Reconstruction is a clinical trial registered under NCT05975372. Current status: RECRUITING.
What is the status of NCT05975372?
The current status of NCT05975372 (Blossom® Smart Expander Device for Tissue Expander/Implant-Based Breast Reconstruction) is: RECRUITING.
When did Blossom® Smart Expander Device for Tissue Expander/Implant-Based Breast Reconstruction start?
Blossom® Smart Expander Device for Tissue Expander/Implant-Based Breast Reconstruction started on 2023-11-17.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.